81 |
Die Rolle der Interleukin-10 Gabe auf die posttraumatische systemische Inflammation und Organdysfunktion am MausmodellSchreiber, Helen 24 April 2012 (has links)
Bei IL-10 handelt es sich um ein antiinflammatorisches Zytokin, dessen
immunmodulatorische Effekte bereits in zahlreichen Studien aufgezeigt werden konnten. Ziel dieser Studie war, die Unterschiede in der systemischen Inflammation und Organdysfunktion an Mäusen zu untersuchen, die nach Induktion eines hämorrhagischen Schocks, entweder inhalativ oder systemisch, mit IL-10 behandelt wurden. Männliche C57/BL6 Mäuse (6 Tiere pro Gruppe) wurden für 1.5 Stunden blutdruckkontrolliert in einen hämorrhagischen Schock versetzt. Nach anschließender Volumensubstitution wurde ihnen inhalativ oder intraarteriell rekombiniertes Maus - IL-10 verabreicht. Nach einer Gesamtversuchsdauer von 6 - bzw. 24 Stunden erfolgte die Tötung der Tiere. Die Ergebnisse der Studie zeigen, dass die lokale und systemische Verabreichung von IL-10 das Zytokinprofil der systemischen Inflammationsantwort unterschiedlich beeinflusst. Die Lunge kann durch inhalative Gabe von IL-10 geschützt werden, ohne die systemische Inflammationsantwort zu beeinflussen.
|
82 |
Vers une meilleure évaluation des risques liés à une exposition aux nanoparticules d'argent : inhalation et toxicocinétiqueAndriamasinoro, Sandra Nirina 09 1900 (has links)
Les nanoparticules (NP) figurent aux premiers rangs des contaminants émergents prioritaires dans le champ de surveillance des grands organismes de santé et sécurité du travail. Parmi les NP les plus utilisées, on peut citer les NP d’argent (Ag). L’exposition humaine aux NP d’Ag augmente alors inévitablement avec l’accroissement de leur production et leur utilisation généralisée ce qui suscite des préoccupations sur les risques à la santé. L'objectif du projet est de mieux documenter le devenir des NP d’Ag dans l’organisme, à partir d’études expérimentales chez l’animal exposé sous différentes conditions par inhalation, la principale voie d’exposition des travailleurs. Ces informations sont nécessaires pour le développement sécuritaire de ces nouvelles technologies.
Dans un premier temps, le profil toxicocinétique des NP d’Ag inhalées a été documenté. Les rats ont été exposés « nez seulement » à des NP de 20 nm pendant 6 h à une concentration cible de 15 mg/m3. L'évolution temporelle de l'élément Ag dans les poumons, le sang, les tissus et les excrétas a été déterminée pendant 14 jours après le début de l'inhalation. La cinétique des NP d’Ag inhalées a été ensuite comparée avec la cinétique d’une forme soluble de l’élément Ag suite à l’exposition au nitrate d’argent (AgNO3) dans de mêmes conditions expérimentales pour mieux comprendre leur comportement, principalement, en raison de leur dissolution et leur capacité à libérer progressivement des ions Ag+ en milieu biologique. Ainsi, dans un dernier temps, dans le but de déterminer la meilleure métrique à utiliser pour mieux évaluer les risques associés à ces NP d’Ag, nous avons étudié l’impact de la cinétique entre un nombre plus faible et un nombre plus élevé de particules.
Les profils cinétiques des NP d’Ag inhalées ont montré que la fraction de la dose inhalée qui a atteint les poumons est rapidement éliminée au cours des 72 premières heures suivant l'inhalation, puis la fraction restante de la dose est lentement éliminée par la suite. La dose inhalée éliminée des poumons semble être transférée dans la circulation systémique et atteint un maximum entre 48 et 72 h après l'inhalation. Cependant, les niveaux d'Ag dans le sang étaient faibles, ce qui suggère une biodistribution rapide dans les tissus tels que le foie, l’organe cible des NP d’Ag chez le rat après inhalation. Une translocation vers le bulbe olfactif et les ganglions lymphatiques était évidente durant l'exposition par inhalation de 6 h jusqu'à 6 h après la fin de l'exposition, démontrant l’occurrence d’un transport direct des NP d’Ag via le nerf nasal par le transport axonal et via la circulation lymphatique après la clairance pulmonaire, respectivement. Les profils d'excrétion ont également révélé que l'excrétion fécale est la voie d'excrétion dominante pour les NP d’Ag.
Les résultats obtenus après l'inhalation d'AgNO3 ont montré des différences dans la cinétique de l’Ag sous la forme soluble par rapport à la forme insoluble (nanoparticulaire) avec des niveaux plus élevés dans le sang, le tractus GI et les tissus extrapulmonaires, mais des niveaux plus faibles dans les poumons. En plus de ces observations, l'évolution temporelle de l’Ag dans le tube digestif et les fèces après l'exposition à la forme soluble était associée à une réabsorption intestinale de l'Ag. Une fraction plus élevée de la dose a été également récupérée dans les reins et l'urine pour les formes solubles d’Ag; en effet, la filtration glomérulaire des agrégats de NP d’Ag peut être limitée alors que le cation monovalent dissous peut plus facilement passer dans le filtrat du sang.
Notre étude a également révélé des différences significatives dans les profils temporels de l'Ag dans les poumons, le sang, les ganglions lymphatiques et le tractus gastro-intestinal entre les rats exposés à des aérosols de NP d'Ag avec un nombre faible et un nombre élevé de particules, mais dont la concentration massique est identique. Certaines similitudes entre les deux conditions ont également été notées, telles que la distribution tissulaire relative, le temps jusqu'aux niveaux de pointe (Tmax) et les profils d'excrétion. Cependant, pour confirmer si le modèle de biodistribution des NPs d'Ag est conditionné par le nombre de particules, des investigations supplémentaires sont nécessaires. / Nanoparticles (NPs) are among the top priority emerging contaminants in the monitoring field of the major occupational health and safety organizations. Among the most widely used nanoparticles, we can cite silver nanoparticles (Ag). Human exposure to Ag NPs inevitably increases with the increase in their production and their widespread use which raises concerns about the health risks. The objective of the project is to better document the fate of Ag nanoparticles in the body, based on experimental studies in animals exposed under different conditions by inhalation, the main route of exposure for workers. This information is necessary for the safe development of these new technologies.
First, the toxicokinetic profile of inhaled Ag NPs was documented. Rats were exposed "nose only" to 20 nm NPs for 6 h at a target concentration of 15 mg/m3. The temporal evolution of the Ag element in the lungs, blood, tissues and excreta was determined for 14 days after the start of inhalation. Thus, to better understand their behavior, mainly because of their dissolution and their capacity to progressively release Ag+ ions in the biological medium, the kinetics of inhaled Ag NPs were compared with the kinetics of a soluble form of the element Ag following exposure to silver nitrate (AgNO3) under the same experimental conditions. Thus, as a last step, in order to determine the best metric to use to better assess the risks associated with these Ag NPs, we studied their kinetic from inhalation studies by comparing the effect of a lower -number with a higher- number of particles.
The kinetic profiles of inhaled Ag nanoparticles showed that the fraction of the inhaled dose that reached the lungs is rapidly eliminated during the first 72 hours after inhalation, and the remaining fraction of the dose is slowly eliminated thereafter. The inhaled dose cleared from the lungs appears to be transferred to the systemic circulation and reaches a maximum between 48 and 72 hours after inhalation. However, Ag levels in the blood were low, suggesting rapid biodistribution to tissues such as the liver, the target organ of Ag nanoparticles in rats after inhalation. A translocation of Ag NPs in olfactory bulbs and lymph nodes was apparent, demonstrating the occurrence of direct transport of Ag NPs through nasal nerve by axonal transport and via lymphatic circulation after lung clearance, respectively. The excretion profiles also revealed that fecal excretion is the dominant excretion route for Ag nanoparticles.
The results obtained after inhalation of AgNO3 showed differences in the kinetics of soluble AgNO3 compared to insoluble Ag NPs, with higher levels in blood, GI tract and extrapulmonary tissues, but lower levels in lungs. In addition to these observations, the time courses of Ag elements in the GI tract and feces following ionic form exposure were compatible with an intestinal reabsorption of Ag. A higher fraction of the dose was further recovered in kidneys and urine after AgNO3 inhalation compared to Ag NP inhalation. Indeed, filtration of Ag NP aggregates may be restricted while the dissolved Ag+ monovalent ion can more easily pass into the filtrate from blood.
Our study also revealed significant differences in the time profiles of Ag element in lungs, blood, lymphatic nodes and GI tract between rats exposed to Ag NPs aerosols of lower- and higher-total particle number counts, but with the same mass concentration. Some similarities between the two conditions were also noted, such as the relative tissue distribution, time-to-peak levels (Tmax) and excretion profiles. However, to confirm if the biodistribution pattern of Ag NPs is conditioned by the particle number, further investigations are needed.
|
83 |
Neurotoxicity and neurobehavioral effects of manganese phosphate/sulfate mixture in male sprague-dawley rats following subchronic inhalation exposureSalehi, Fariba January 2005 (has links)
Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.
|
84 |
Suboptimal use of inhaled corticosteroids in children with persistent asthma : inadequate physician prescription, poor patient adherence or both ?Pando, Silvia January 2008 (has links)
Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.
|
85 |
PULMONARY DELIVERY OF ANORECTIC GUT SECRETED PEPTIDES FOR APPETITE SUPPRESSION IN RATSNadkarni, Priya 01 January 2009 (has links)
This dissertation project aimed to demonstrate that pulmonary delivery of two anorectic gut secreted peptides, peptide YY (PYY) and oxyntomodulin (OXM) enabled food intake suppression and reduced body weight gain in rats via their systemic absorption from the lung and interaction with the brain. After PYY and OXM were administered to the lungs at varying doses, food intake and body weight gain were monitored in freely feeding rats. Significant 30-35 % food intake suppression was achieved for 4-6 h following pulmonary administration of endogenously active PYY3-36 and OXM1-37 at 0.80 and 0.50 mg/kg, respectively. Moreover, when administered daily for 7 days, these peptides enabled significant reduction of body weight gain by 39.4 and 62.3 %, respectively. However, neither of their active fragment peptides, PYY13-36, OXM30-37 and NAc-OXM30-37 was effective at doses equimolar to the effective doses of PYY3-36 and OXM1-37. For PYY3-36, its pulmonary administration caused c-Fos activation in the hypothalamus arcuate nucleus (ARC) only, which was concurrent to reduced orexigenic neuropeptide Y (NPY), suggesting its appetite suppression was mediated via the central nervous system (CNS). In contrast, OXM1-37 caused c-Fos activation in both the hypothalamus ARC and brainstem AP, which implied the involvement of the CNS control and vagal stimulation for this peptide. As it was clear that these effects resulted from their lung absorption and increased plasma levels, the pharmacokinetics of one of the peptides, PYY3-36 was characterized following pulmonary administration. The plasma profiles were dose-proportional and kinetically, non “flip-flop”, yielding the highest PYY3-36 concentrations (Cmax) of 75.0±9.3 and 726.3±69.0 ng/ml at 0.08 and 0.80 mg/kg, respectively, at 10 min. According to a new kinetic model developed in this project, the percent absolute bioavailability (% F) was estimated to be 12-14 %, as derived from the lung absorption (ka) and non-absorptive loss rate constant (knal) of 0.03 min-1 and 0.17-0.22 min-1, respectively. Overall, this research provided the first proof-of-concept for effective appetite suppression with pulmonary delivery of anorectic gut secreted peptides via systemic absorption.
|
86 |
Effect of Storage Humidity on Physical Stability and Aerosol Performance of Spray-Dried Dry Powder Inhaler FormulationsNivedita J Shetty (6955364) 15 August 2019 (has links)
<p>Dry Powder inhalers (DPIs) have
been one of the most promising developments in pulmonary drug delivery systems.
In general, DPIs are more effective than systemic administrations and convenient
to use. However, delivering high-dose antibiotics through a DPI is still a
challenge because high powder load may need a very large inhaler or increase
the incidence of local adverse effects. Spray drying has been increasingly
applied to produce DPI formulations for high-dose antibiotics; nevertheless,
many spray-dried particles are amorphous and physically unstable during
storage, particularly under the humid environment. </p>
<p> </p>
<p>My research focuses on addressing
critical challenges in physical stability of DPIs for spray-dried high-dose
antibiotics. The effects of moisture-induced crystallization on physical
stability and aerosol performance of spray-dried amorphous Ciprofloxacin DPI
formulations stored at different humidity conditions were studied. Our study
not only provided a mechanistic understanding in the impact of crystallization
on aerosol performance but also developed novel approaches for improving
stability of spray-dried formulations used in DPI.</p>
<p> </p>
<p>Our work has shown that
recrystallization of amorphous spray-dried Ciprofloxacin led to significant
changes in aerosol performance of DPIs upon storage, which cause critical
quality and safety concerns. These challenges have been solved through co-spray-drying
Ciprofloxacin with either excipient such as leucine or synergistic antibiotic
like Colistin. Co-spray-drying Ciprofloxacin with Colistin not only improved
physical and aerosol stability but also enhanced antibacterial activity which
is a great advantage for treating ‘difficult to cure’ respiratory infections
caused by multidrug resistant bacteria.</p>
<p> </p>
<p>My research work is a sincere
effort to maximize the utility and efficacy of high-dose DPI, an effective
delivery tool for treating severe resistant bacterial respiratory infections.</p>
|
87 |
"Poeira de soja inalada e seu impacto epidemiológico no desencadeamento de alergia respiratória" / Dust of inhaled soy and its epidemic impact in the respiratory allergyPinto, Rodolpho José de Carvalho 20 June 2006 (has links)
Introdução: surtos de asma, por poeira da soja, têm sido relatados, havendo casos fatais. Objetivo: correlacionar exposição, sensibilização e alergia respiratória a esta, no Brasil. Métodos: 590 voluntários (testes de punctura e dosagem de IgE específica). Resultados: operários da indústria apresentaram 15% de. sensibilização à soja. Caminhoneiros 22%. Moradores no entorno da indústria 22% enquanto aqueles que residem distantes 6%. .Na região agrícola distante das plantações 13% e em meio à soja 28% com 5% de sensibilizados somente à soja. O percentual de IgE positivas para soja foi 16%. Houve marcante sensibilização aos fungos. Conclusão: A prevalência de sensibilização à soja demonstra o impacto desse tipo de poluição. A sensibilização aos fungos que colonizam a soja estocada não deve ser subestimada / Background: Asthma outbreaks, by soybean dust inhalation, have been reported fatal cases.. Objective: To correlate exposure and sensitization to soybean dust in Brazil.. Methods: 590 volunteers exposed to soy dust. Prick skin tests were performed and specific IgE were measured in sera.. Results: the workers from the oil refinery had sensitization to soy (15%). Truck drivers 22%. Industry neighborhood 22%. and people who live far from this place presented only 6%. People from agricultural area far from the soy plantations 13% and in the middle of the soy 28%.with 5% sensitized only by soybean . Positive IgE was 16 %. Conclusion: a high prevalence of sensitivity to soybean hull demonstrates the impact of this kind of pollution. The sensitization to the fungi which colonize soybean storage can not be underestimated
|
88 |
Anestesia inalatória em ovinos: estudo comparativo entre o halotano, isofluorano e sevofluorano / Inhalation anesthesia in sheep: comparative research of halothane, isoflurane and sevofluraneMattos Junior, Ewaldo de 29 May 2012 (has links)
Foram utilizados vinte ovinos, machos com idade entre um e três anos, com peso médio de 33,1 ± 3,1 kg. Os animais foram distribuídos de forma aleatória em três grupos, designados como GH (halotano), GI (isofluorano) e GS (sevofluorano) em experimento do tipo cruzado com intervalo mínimo de 1 semana entre os tratamentos. Numa primeira etapa, os animais foram anestesiados com auxílio de máscara facial, intubados e mantidos sob anestesia com agente segundo a determinação de cada grupo e obtida a concentração alveolar mínima (CAM) dos agentes por meio de estímulo nociceptivo com eletroestimulação. Em uma segunda etapa, os animais foram mantidos com a CAM previamente compreendendo os momentos de M0 a M8 com intervalo de 15 minutos entre os mesmo. Foram avaliadas as funções hemodinâmicas, respiratórias, hemogasométricas, endócrinas e o índice biespectral. Os valores médios de CAM foram de 0,71 ± 0,09%, 1,31 ± 0,33% e 2,69 ± 0,29% para o halotano, isofluorano e sevofluorano respectivamente. Houve redução dos valores do índice cardíaco no GI em todos os momentos comparativamente ao basal (p<0,001); na comparação entre os grupos os valores do M0 no GI foram superiores aos verificados em GH e GS (p<0,01). O valores do volume e índice sistólico foram inferiores ao basal a partir de M6 no grupo GH (p<0,05) e no GI todos os momentos foram inferiores ao basal (p<0,001); na comparação entre os grupos verificou-se que os valores dessas variáveis no momento M0 no GI foram superiores a GH (p<0,05) e GS (p<0,001). As médias da pressão venosa central foram inferiores no grupo GH em todos os momentos comparativamente a M0 (p<0,001), e neste mesmo momento, as médias foram superioriores comparativamente aos outros grupos (p<0,05). Quanto ao índice de resistência vascular sistêmica, os valores foram superiores nos momentos M6, M3 e M7 nos grupos GH (p<0,05), GI (p<0,001) e GS (p<0,01), respectivamente; houve incremento do índice de resistência vascular periférica no momento M7 (p<0,01) no grupo GH a partir de M3 (p<0,001), em GI e em M7 e M8 (p<0,05) comparativamente ao basal. Os valores de tensão de dióxido de carbono no final da expiração foram superiores no grupo GH a partir de M4 (p<0,05) e no GI a partir de M3 (p<0,01) comparativamente ao basal. Os valores do índice biespectral no GI, foram superiores a partir de M5 em relação ao valor basal (p<0,01); na comparação entre os grupos, os momentos M2 e M3 foram inferiores no GI comparativamente ao GH e GS (p<0,05). Houve redução da temperatura retal em todos os grupos e momentos comparativamente ao valor basal (p<0,001). O período de recuperação foi superior no grupo GH (p<0,05). Nas condições do presente estudo a CAM em ovinos é de 0,71%, 1,31% e 2,69% para o halotano, isofluorano e sevofluorano respectivamente; os três agentes promovem redução do débito cardíaco e do volume sistólico; os valores do índice biespectral são semelhantes entre os fármacos, com valores inferiores quando tratados com isofluorano; há indução de estresse neuroendócrino avaliado por meio da dosagem de cortisol; os agentes promovem hipotermia tempo dependente; o halotano promove recuperação anestésica mais prolongada. / Twenty sheep, all males, were used in this experiment. Age ranged from one to three years and mean weight was 33.1 ± 3.1 kg. In a crossover design, animals were randomly treated with halothane (GH), isoflurane (GI) and sevoflurane (GS), with interval of 1 week between treatments. In a first phase, anesthesia was induced by facemask, animals were then intubated and anesthesia maintained with one of the three treatments. Minimum alveolar concentration (MAC) was obtained by nociceptive stimulation for each animal. In phase 2, the animals were anesthetized again by facemask and maintained at the predetermined MAC (Phase 1) for two hours. Data was collected at moments (M0-M8) with intervals of 15 minutes. Cardiovascular, respiratory and bispectral index parameters were recorded. Blood gas analysis, CBC and cortisol levels were also measured and recorded. MAC of each group were 0.71± 0.09%, 1.31 ± 0.33% e 2.69 ± 0.29% for GH, GI and GS respectively. There was a reduction in cardiac index in GI at all times compared to baseline (p<0.001). Among groups the values of M0 in GI were higher than those in GH and GS (p<0.01). In GH, the end systolic volume and stroke index were lower than baseline from M6 until the end of the experiment (p<0.05). In GI, ESV and SI were below the baseline at all times (p<0.001). Among groups it was found that the GI baseline values of these variables were higher than GH (p<0.05) and GS (p<0.001). The mean central venous pressure were lower in the GH group at all times compared to M0 (p<0.001), which was higher than the baseline of the other groups (p<0.05). When compared to baseline, systemic vascular resistance index was higher in the moments M6, M3 and M7 in GH (p<0.05), GI (p<0.001) and GS (p<0.01), respectively. There was an increase in peripheral vascular resistance index (PVRI) at the time M7 (p<0.01) in GH from M3 to the end of the study (p<0.001). In GI, PVRI was increased at M7 and M8 (p<0.05) in comparison to baseline. The values of end-tidal of carbon dioxide were higher than baseline in the GH group from M4 (p<0.05) until the end of study. The same occurred in GI starting at M3 (p<0.01). In GI, the bispectral index values were higher starting at M5 to the end when compared to baseline (p<0.01). Among groups, BIS was lower at M2 and M3 in GI when compared to GH and GS (p< 0.05). Rectal temperature decreased in all groups at all moments in comparison to baseline (p<0.001). The recovery period was longer in GH (p<0.05). Under this study conditions MAC in sheep were 0.71%, 1.31% and 2.69% for halothane, isoflurane and sevoflurane, respectively. All treatments further reduced cardiac output and stroke volume; bispectral index values were similar among drugs, with lower values when treated with isoflurane. A stress response was believed to be induced due to elevation of serum cortisol in all groups. These inhalants promote time-dependent hypothermia. Halothane anesthesia promotes prolonged recovery.
|
89 |
Efeitos do oxigênio umidificado e não umidificado via cateter nasal sobre o transporte mucociliar e muco nasal / The effects of humidified and dry oxygen via nasal catheter on mucociliary clearance and mucusFranchini, Michelle Lisidati 04 March 2016 (has links)
O transporte mucociliar (TMC) é um mecanismo básico de defesa do sistema respiratório necessário na resistência à infecção. A efetividade desse mecanismo de defesa depende da composição e profundidade do muco, da integridade e da função dos cílios e da interação muco-cílio. O objetivo deste estudo foi investigar os efeitos crônicos do oxigenoterapia de baixo fluxo via cateter nasal com e sem umidificação sobre o TMC nasal, nas propriedades físicas do muco, na inflamação e nos sintomas de vias aéreas em pacientes com hipoxemia crônica com necessidade de oxigenoterapia domiciliar de longo prazo (>15 horas/dia). Dezoito pacientes (idade média de 68 anos, 7 do sexo masculino, índice de massa corpórea (IMC) médio de 26 kg/m2, 66% com doença pulmonar obstrutiva crônica (DPOC), 60% com hipertensão arterial (HAS) e ex-tabagistas) iniciando oxigenoterapia de baixo fluxo via cateter nasal foram randomizados para o grupo Oxigênio Seco (n=10) ou Oxigênio Umidificado (n=9). Os pacientes foram avaliados nos tempos: basal, 12 horas, 7 dias, 30 dias, 12 meses e 24 meses para o TMC nasal por meio do teste de trânsito da sacarina, as propriedades físicas do muco por meio de ângulo de contato, a inflamação por meio de quantificação do número total de células e diferenciais e da concentração de citocinas no lavado nasal assim como para sintomas por meio do questionário SNOT-20. O sintoma mais importante relatado por pacientes no basal foi tosse que melhorou após 7 dias de oxigenoterapia. No nosso estudo, os pacientes de ambos grupos apresentaram prolongamento significativo (40%) do TMC nasal ao longo do estudo. O lavado nasal mostrou um aumento das proporções de neutrófilos, das células caliciformes e da concentração do fator de crescimento epidermal (EGF) assim como reduções em macrófagos e concentrações de interferon alfa (IFN-alfa), interleucina (IL)-8 e IL-10 ao longo do estudo. Não houve alterações na proporção de células ciliadas, na concentração de IL-6 e no ângulo de contato do muco em ambos os grupos. A tosse e os sintomas de sono diminuiram significativamente em ambos os grupos. Nosso estudo sugere que a umidificação não tem impacto sobre o TMC nasal, as propriedades do muco, a inflamação e os sintomas em pacientes com baixo fluxo de oxigênio via cateter nasal (BFON) / Mucociliary clearance (MCC) is a basic defense mechanism of the respiratory system against respiratory infection. The efficiency of this defense mechanism depends on the mucus composition and mucus depth, on the cilia integrity and function and the mucus-cilia interaction. The aim of this study was investigate the long-term effects of low-flow oxygen via nasal catheter (NLFO) using dry oxygen (Dried-NLFO) or humidified oxygen (Humidified-NLFO) on nasal mucociliary clearance, mucus properties, inflammation and symptoms in patients with chronic hypoxemia requiring long-term domiciliary oxygen therapy ( > 15 hours/day). Eighteen patients (mean age of 68 years, 7 male, mean BMI of 26 kg/m2, 66% COPD, 60% hypertensive and former smokers) initiating NLFO were randomized to Dried-NLFO (n=10) or Humidified-NLFO (n=9). Patients were assessed at baseline and along 12 hours, 7 days, 30 days, 12 months and 24 months for nasal MCC using saccharine test, mucus properties by means of contact angle, inflammation using total number of cells and cytokines concentration in nasal lavage fluid as well as symptoms by SNOT-20 questionnaire. The most important airway symptom reported by patients at baseline was cough that improved after 7 days of oxygen therapy. In our study, nasal MCC prolonged significantly (40%) and similarly in both groups along the study. Nasal lavage showed increased proportions of neutrophils, goblet cells and epidermal growth factor concentration as decreases in macrophages, IFN-a lfa, IL-8 and IL-10 concentrations along the study. No changes in the proportion of ciliated cells, IL-6 and mucus contact angle were observed in both groups. Coughing and sleep symptoms significantly decreased similarly in both groups. Our study suggests that humidification does not impact on nasal MCC, mucus properties, inflammation and symptoms in patients using NLFO
|
90 |
Determinação de resíduos de hexaclorociclohexano \"HCH\" no soro sanguíneo de trabalhadores expostos no Arquivo Histórico de Joinville na década de 80 / Determination of hexachlorcyciohexane residues on blood plasma of exposed employees of the Historical Archieve of Joinville on 80\'s decadeLoiola, Elaine Cristina Damasceno 13 December 2007 (has links)
O Hexaclorociclohexano (HCH) é um inseticida do grupo dos organoclorados, composto por uma mistura de isômeros formados durante a síntese química, através de sucessivas adições de cloro ao benzeno. Estes isômeros podem contaminar não só o meio ambiente como também a população que tenha contato direto ou indireto com os resíduos. Nas décadas de 70 e 80, foi utilizado um produto comercial composto pelo ativo HCH comercializado como \"Hexabel®\" no controle de insetos xilófagos no Acervo Histórico de Joinville em Santa Catarina. A aplicação do inseticida foi realizada pelos próprios funcionários do Arquivo Histórico, e houve intensa manipulação dos documentos tratados durante uma mudança do prédio o presente trabalho teve como objetivo validar uma metodologia de determinação de resíduos do HCH e seus isômeros em soro sangüíneo, e analisar o grau de exposição dos funcionários e ex-funcionários do Arquivo Histórico de Joinville ao produto. Foram realizados exames sorológicos em todos os funcionários e ex - funcionários do local e também na população que sabidamente nunca tiveram contato com o ativo, denominada população controle. As análises foram realizadas após a validação do método multiresíduos que obtém todos os ativos em uma única extração e tem detecção por Cromatografia a gás com detector de captura (GC-ECD) de elétrons. Os resultados comprovaram comprovaram a eficiência do método, através de dados em conformidade com os critérios do ensaio. Os resultados obtidos no estudo da população mostraram que a quantidade de HCH no soro sangüíneo de funcionários, ex-funcionários e da população controle estão abaixo do limite de quantificação de 0,04μg dL-1 para Alfa HCH e Gama HCH \"Lindana\" e 0,08μg dL-1 para Beta e Delta HCH. / Hexachlorcyciohexane (HCH) is an organochloride insecticide formed by a mixture of chemical isomers produced during its chemical synthesis, obtained after successive inserts of chlorine atoms on benzene molecule. These isomers may contaminate both the environment and the people who had direct or indirect contact with the HCH residues. On 70\'s and 80\'s, its was used a commercial product which contained HCH on its formula and was commercialized as Hexabel®. The product was used to control the xylophage insect population on the Historical Archieve of Joinville, at Santa Catarina, Brazil. The own employees did the insecticide application and there was an intensive manipulation of the treated material during a building change. The objective of this work was to validate a methodology to quantify the HCH residues and its isomers on blood plasma and analyze the employee\'s exposure extent to the chemical. It was done serological investigation on employees, former-employees and on non-exposed people, which was classified as the control population. The analyses were done after the methodology validation. The method was capable to obtain all isomers on a unique extraction and the detection and quantification were done by gas chromatography with electron-capture detector (GC-ECD). The results obtained showed that the proposed method is accurate, and that the amount of HCH residues on blood plasma of all individuals analyzed was lower than the quantification limits established to the method, which were 0,04 μg dL-1 for the alpha- and gamma- HCH (lindana) and 0,08 μg dL-1 for the beta- and delta- HCH.
|
Page generated in 0.0192 seconds